Bank of New York Mellon’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-102,516
| Closed | -$49K | – | 4386 |
|
|
2016
Q1 | $49K | Sell |
102,516
-8,993
| -8% | -$4.3K | ﹤0.01% | 4087 |
|
|
2015
Q4 | $75K | Buy |
111,509
+5,845
| +6% | +$3.93K | ﹤0.01% | 4083 |
|
|
2015
Q3 | $102K | Buy |
105,664
+3,147
| +3% | +$3.04K | ﹤0.01% | 4056 |
|
|
2015
Q2 | $123K | Buy |
102,517
+7,048
| +7% | +$8.46K | ﹤0.01% | 4000 |
|
|
2015
Q1 | $101K | Sell |
95,469
-343
| -0.4% | -$363 | ﹤0.01% | 4039 |
|
|
2014
Q4 | $104K | Buy |
95,812
+344
| +0.4% | +$373 | ﹤0.01% | 4024 |
|
|
2014
Q3 | $104K | Sell |
95,468
-1
| -0% | -$1 | ﹤0.01% | 4037 |
|
|
2014
Q2 | $100K | Sell |
95,469
-164,267
| -63% | -$172K | ﹤0.01% | 3993 |
|
|
2014
Q1 | $268K | Sell |
259,736
-11,418
| -4% | -$11.8K | ﹤0.01% | 3753 |
|
|
2013
Q4 | $315K | Sell |
271,154
-77,924
| -22% | -$90.5K | ﹤0.01% | 3705 |
|
|
2013
Q3 | $586K | Buy |
349,078
+88,909
| +34% | +$149K | ﹤0.01% | 3455 |
|
|
2013
Q2 | $520K | Buy |
+260,169
| New | +$520K | ﹤0.01% | 3480 |
|